These data endorsed that mortalin enrichment was clinically relevant and correlated well with the progression of oral cancer to advanced stages as defined by histological grades, clinical stages, and lymph node metastasis. This evidence concerns the gene HSPA9 and lip and oral cavity carcinoma.